Discriminating between Alzheimer patients and healthy persons from circulating miRNA biomarkers

11 Pages

© 2020 Gnosis Data Analysis. All Rights Reserved. ? ? ?© 2020 Gnosis Data Analysis. All Rights Reserved. ?© 2020 Gnosis Data Analysis. All Rights Reserved. ? ? ? ? ?© 2020 Gnosis Data Analysis. All Rights Reserved. ? ? ?© 2020 Gnosis Data Analysis. All Rights Reserved. © 2020 Gnosis Data Analysis. All Rights Reserved. © 2020 Gnosis Data Analysis. All Rights Reserved. © 2020 Gnosis Data Analysis. All Rights Reserved. ? JADBio, applied to Leidinger P et al.’s, miRNA data, produces accurate diagnostic models that are on par with the ones presented in the original publication. ? Furthermore, JADBio requires no expert knowledge of advanced machine learning techniques. ? These results show JADBio can produce a diagnostic model for early diagnosis of Alzheimer's disease in a automa

Join for free to read

Case Study miRNA CDx WORKFLOW

Case Study To Evaluate Cutaneous & Circulating Biomarkers for a Novel…

Case Study How KNIME helped Centogene identify biomarkers & improve…

White Paper Metabolomics for Pharmaceutical Applications - Vol 2

More from JADBio

Case Study Predicting Survival after Surgery from miRNAs profiles in Low…

Case Study The Importance of Objective Stool Classification in Fecal1H-NMR…

Case Study Metabolites

Case Study Automated machine learning optimizes and accelerates predictive…

Case Study

Discriminating between Alzheimer patients and healthy persons from circulating miRNA biomarkers

Discriminating between Alzheimer patients and healthy persons from circulating miRNA biomarkers

Related Solution Sets

You Might Also Like

More from JADBio